Cargando...
Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agent for the treatment of type 2 diabetes mellitus. They increase endogenous levels of incretin hormones, which stimulate glucose-dependent insulin secretion, decrease glucagon secretion, and contribute to reducing postp...
Gardado en:
| Publicado en: | Diabetes Metab J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Korean Diabetes Association
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069390/ https://ncbi.nlm.nih.gov/pubmed/27766241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2016.40.5.339 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|